U.S. FDA approves AstraZeneca's diabetes drug for treating heart failure risk

AstraZeneca Plc said on Monday U.S. regulators approved its diabetes drug Farxiga to be used as a treatment to reduce the chances of hospitalization for heart failure in adults with type-2 diabetes and other cardiovascular risks.

from Reuters: Health News https://ift.tt/2MYiSxT